Its all good guys... whatever demand Inavir cant meet due to capacity constraints will most likely be picked up by Relenza (& higher royalty) in Japan.
Relenza is still doing well in Japan...
BTA Price at posting:
$1.28 Sentiment: Buy Disclosure: Held